Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Whole Blood Immune Cells Characterization in Critically Ill COVID-19 Patients: A Prospective Study

NCT04386395 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT04386395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04386395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Whole Blood Immune Cells Characterization in Critically Ill COVID-19 Patients: A Prospective Study
Lead sponsor
Central Hospital, Nancy, France
Phase
Observational
Overall status
Completed
Start date
March 30, 2020
Completion date
June 30, 2021
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune system disorder, sars-cov-2